Oral Abstract Session: Pre-clinical and clinical application of xenotransplantation and current barriers 4
Saturday October 28, 2023 from 10:00 to 11:30
Indigo D
Moderators
Lectures
-
311.1 Ischemia minimization is associated with improved cardiac function in an ex vivo xeno working heart modelGannon McGrath, United States
-
311.2 Immunotranscriptomic Changes During Two Pig-to-Human Kidney Xenotransplantation CasesHarvey Pass, United States
-
311.3 PCR and peptide based PCMV detection in pig - development and application of a combined testing procedure differentiating newly from latent infected pigsDr. Antonia W. Godehardt, Germany
-
311.4 Incidence of serum antibodies to xenoantigens on triple-knockout pig cells in different human groupsMr. Songzhe He, People's Republic of China
-
311.5 Pilot Evaluation of a Clinical Xeno Heart Transplant Regimen in a Preclinical ModelDr. Ikechukwu S Ileka, United States
-
311.6 Extended Survival of 9- and 10-Gene-Edited Pig Heart Xenografts with Ischemia Minimization and CD154 Costimulation Blockade-Based ImmunosuppressionDr. Ikechukwu S Ileka, United States
-
311.7 Hypertrophic hearts develop dynamic left ventricular outflow tract obstruction after orthotopic pig-to-baboon xenotransplantationDr. Matthias Längin, Germany
-
311.8 Preservation of Cardiac Xenografts in a Model of Infant Human Cardiac XenotransplantationChace Mitchell, United States
-
311.9 Clinical and prognostic value of echocardiography with global longitudinal strain in the first genetically modified porcine to human cardiac xenotransplantDr. Manjula G Ananthram, United States